# OnCo record natsar-pharmaceuticals (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/natsar-pharmaceuticals/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "natsar-pharmaceuticals" ;
  schema:name "NATSAR Pharmaceuticals"@en ;
  schema:alternateName "Natsar Pharmaceuticals, Inc."@en, "Natsar"@en ;
  schema:description "NATSAR Pharmaceuticals is a Maryland company developing RK-33, a drug that blocks DDX3, a protein many tumours depend on. It plans a first trial in people."@en ;
  schema:url <https://onco.cc/companies/natsar-pharmaceuticals/>, <https://www.natsarpharmaceuticals.com/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://www.natsarpharmaceuticals.com/>, <https://reporter.nih.gov/project-details/11419762> ;
  schema:addressCountry "US" ;
  onco:cancers <https://onco.cc/cancers/tnbc/> ;
  onco:sections <https://onco.cc/fronts/targeted-therapy/> ;
  onco:targets <https://onco.cc/targets/ddx3x/> ;
  onco:drugs <https://onco.cc/drugs/rk-33/> .